Skip to content

    Xeris Biopharma Holdings (XERS) stock price & financials

    View XERS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+6.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $54.27M
    $60.10M
    $60.12M
    $71.54M
    $74.38M
    +37.1%
    $85.81M
    +42.8%
    $83.13M
    +38.3%
    $92.10M
    +28.7%
    Strengthening
    Operating Profit
    -$12.89M
    $1.68M
    -$3.09M
    $4.48M
    $6.73M
    $16.77M
    +899.0%
    $7.92M
    $5.17M
    +15.4%
    Strengthening
    Net Profit
    -$15.74M
    -$5.11M
    -$9.22M
    -$1.93M
    $621.0K
    $11.08M
    $2.23M
    -$31.10M
    -1513.1%
    Weakening
    EPS
    $-0.11
    $-0.06
    $-0.01
    $0.00
    +100.0%
    $0.01
    $-0.18
    -1700.0%
    Weakening
    Other Income
    Interest
    $7.79M
    $7.70M
    $7.30M
    $7.36M
    $7.27M
    -6.7%
    $7.15M
    -7.1%
    $6.88M
    -5.8%
    $6.95M
    -5.6%
    Weakening
    Depreciation
    Profit before Tax
    MarginsOPM
    -23.8%
    2.8%
    -5.1%
    6.3%
    9.1%
    19.6%
    +600.7%
    9.5%
    5.6%
    -10.4%
    Strengthening
    Tax
    ReturnsROIC
    2.2%
    0.7%
    1.3%
    0.3%
    -0.1%
    -103.9%
    -1.6%
    -316.7%
    -0.3%
    -124.2%
    4.4%
    +1513.1%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$37.60M$67.27M$121.97M$67.45M$71.62M$111.04M$121.75M
    Short-Term Investments
    Total Current Assets$152.21M$142.60M$186.82M$156.26M$167.66M$240.31M$274.76M
    Net PP&E$6.71M$6.63M$9.51M$29.18M$28.21M$27.06M$26.61M
    Goodwill$0$22.86M$22.86M$22.86M$22.86M$22.86M$22.86M
    Intangibles$0$131.45M$120.61M$109.76M$98.92M$88.08M$82.66M
    Total Assets$159.15M$304.36M$344.52M$322.60M$323.06M$383.53M$411.90M
    LiabilitiesTotal Current Liabilities$28.21M$79.04M$73.62M$95.19M$100.44M$109.57M$189.57M
    Short-Term Debt$0$15.10M$0$63.78M
    Long-Term Debt$87.02M$88.07M$187.07M$190.93M$217.01M$220.34M$188.81M
    Long-Term Leases$0$9.40M$34.76M$33.26M$31.53M$30.54M
    Total Liabilities$125.39M$209.13M$299.33M$329.38M$352.68M$369.84M$421.64M
    EquityCommon Stock & APIC$6.0K$13.0K$14.0K$14.0K$15.0K$17.0K$18.0K
    Retained Earnings-$337.38M-$460.11M-$554.77M-$617.02M-$671.86M-$671.31M-$700.17M
    Total Equity$33.76M$95.23M$45.19M-$6.78M-$29.61M$13.69M-$9.73M
    HighlightsNet Cash / (Debt)-$123.48M-$160.49M-$109.29M-$130.84M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$80.56M-$95.53M-$102.89M-$47.02M-$36.98M$28.63M$56.61M
    Cash from Investing-$27.41M$97.96M$34.46M-$6.00M$4.88M-$696.0K-$938.0K
    Cash from Financing$126.06M$27.25M$127.47M-$1.61M$36.17M$11.39M$6.69M
    SummaryCapital Expenditure-$377.0K-$1.08M
    Free Cash Flow-$80.94M-$96.62M
    FCF Margin-396.1%-194.8%

    Ratios